Literature DB >> 18434503

Cl-pi interactions in protein-ligand complexes.

Yumi N Imai1, Yoshihisa Inoue, Isao Nakanishi, Kazuo Kitaura.   

Abstract

During systematic analysis of nonbonded contacts in protein-ligand complexes derived from crystal structures in the Protein Data Bank, Cl-pi interactions have been found, not only in the well-documented serine proteases but also, to a lesser extent, in other proteins. From geometric analysis of such Cl-pi interactions in the crystal structures, two distinct geometries were found: the "edge-on" approach of a Cl atom to a ring atom or C-C bond and the "face-on" approach toward the ring centroid with an average interatomic distance of 3.6 A. High-level ab initio calculations using benzene-chlorohydrocarbon model systems elucidated that the calculated Cl-pi interaction energy is -2.01 kcal/mol, and the dispersion force is the major source of attraction. We also discussed the geometric flexibility in Cl-pi interactions and a relationship between the intensity of the pi density in an aromatic ring and the interaction position of the Cl atom.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434503      PMCID: PMC2442010          DOI: 10.1110/ps.033910.107

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  17 in total

1.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.

Authors:  G Kryger; I Silman; J L Sussman
Journal:  Structure       Date:  1999-03-15       Impact factor: 5.006

2.  Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.

Authors:  Albert C Pierce; Kathryn L Sandretto; Guy W Bemis
Journal:  Proteins       Date:  2002-12-01

3.  Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallography.

Authors:  Marc Nazaré; David W Will; Hans Matter; Herman Schreuder; Kurt Ritter; Matthias Urmann; Melanie Essrich; Armin Bauer; Michael Wagner; Jörg Czech; Martin Lorenz; Volker Laux; Volkmar Wehner
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

4.  Estimated MP2 and CCSD(T) interaction energies of n-alkane dimers at the basis set limit: comparison of the methods of Helgaker et al. and Feller.

Authors:  Seiji Tsuzuki; Kazumasa Honda; Tadafumi Uchimaru; Masuhiro Mikami
Journal:  J Chem Phys       Date:  2006-03-21       Impact factor: 3.488

5.  Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide.

Authors:  S Mecozzi; A P West; D A Dougherty
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.

Authors:  T J Tucker; S F Brady; W C Lumma; S D Lewis; S J Gardell; A M Naylor-Olsen; Y Yan; J T Sisko; K J Stauffer; B J Lucas; J J Lynch; J J Cook; M T Stranieri; M A Holahan; E A Lyle; E P Baskin; I W Chen; K B Dancheck; J A Krueger; C M Cooper; J P Vacca
Journal:  J Med Chem       Date:  1998-08-13       Impact factor: 7.446

7.  Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.

Authors:  Susanne Roehrig; Alexander Straub; Jens Pohlmann; Thomas Lampe; Josef Pernerstorfer; Karl-Heinz Schlemmer; Peter Reinemer; Elisabeth Perzborn
Journal:  J Med Chem       Date:  2005-09-22       Impact factor: 7.446

8.  Propensities of polar and aromatic amino acids in noncanonical interactions: nonbonded contacts analysis of protein-ligand complexes in crystal structures.

Authors:  Yumi N Imai; Yoshihisa Inoue; Yoshio Yamamoto
Journal:  J Med Chem       Date:  2007-02-22       Impact factor: 7.446

9.  Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.

Authors:  Sébastien Maignan; Jean-Pierre Guilloteau; Yong Mi Choi-Sledeski; Michael R Becker; William R Ewing; Henry W Pauls; Alfred P Spada; Vincent Mikol
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

10.  Crystal structures of two potent nonamidine inhibitors bound to factor Xa.

Authors:  Marc Adler; Monica J Kochanny; Bin Ye; Galina Rumennik; David R Light; Sara Biancalana; Marc Whitlow
Journal:  Biochemistry       Date:  2002-12-31       Impact factor: 3.162

View more
  36 in total

Review 1.  Halogenase engineering and its utility in medicinal chemistry.

Authors:  Amy E Fraley; David H Sherman
Journal:  Bioorg Med Chem Lett       Date:  2018-04-30       Impact factor: 2.823

2.  Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators.

Authors:  Pieter B Burger; Hongjie Yuan; Erkan Karakas; Matthew Geballe; Hiro Furukawa; Dennis C Liotta; James P Snyder; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

3.  Structural and biophysical characterization of human cytochromes P450 2B6 and 2A6 bound to volatile hydrocarbons: analysis and comparison.

Authors:  Manish B Shah; P Ross Wilderman; Jingbao Liu; Hyun-Hee Jang; Qinghai Zhang; C David Stout; James R Halpert
Journal:  Mol Pharmacol       Date:  2015-01-13       Impact factor: 4.436

4.  Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors.

Authors:  Gilles Ouvry; Laurence Clary; Loïc Tomas; Michèle Aurelly; Laetitia Bonnary; Emilie Borde; Claire Bouix-Peter; Laurent Chantalat; Claire Defoin-Platel; Sophie Deret; Mathieu Forissier; Craig S Harris; Tatiana Isabet; Laurent Lamy; Anne-Pascale Luzy; Jonathan Pascau; Catherine Soulet; Alessandro Taddei; Nathalie Taquet; Etienne Thoreau; Emeric Varvier; Emmanuel Vial; Laurent F Hennequin
Journal:  ACS Med Chem Lett       Date:  2019-10-04       Impact factor: 4.345

5.  Halogen-π Interactions in the Cytochrome P450 Active Site: Structural Insights into Human CYP2B6 Substrate Selectivity.

Authors:  Manish B Shah; Jingbao Liu; Qinghai Zhang; C David Stout; James R Halpert
Journal:  ACS Chem Biol       Date:  2017-04-06       Impact factor: 5.100

6.  SAR Studies of Indole-5-propanoic Acid Derivatives To Develop Novel GPR40 Agonists.

Authors:  Dong-Oh Yoon; Xiaodi Zhao; Dohyun Son; Jung Tae Han; Jaesook Yun; Dongyun Shin; Hyun-Ju Park
Journal:  ACS Med Chem Lett       Date:  2017-11-21       Impact factor: 4.345

Review 7.  A medicinal chemist's guide to molecular interactions.

Authors:  Caterina Bissantz; Bernd Kuhn; Martin Stahl
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

8.  Potent peptidic fusion inhibitors of influenza virus.

Authors:  Rameshwar U Kadam; Jarek Juraszek; Boerries Brandenburg; Christophe Buyck; Wim B G Schepens; Bart Kesteleyn; Bart Stoops; Rob J Vreeken; Jan Vermond; Wouter Goutier; Chan Tang; Ronald Vogels; Robert H E Friesen; Jaap Goudsmit; Maria J P van Dongen; Ian A Wilson
Journal:  Science       Date:  2017-09-28       Impact factor: 47.728

9.  Lone pair ... pi interactions between water oxygens and aromatic residues: quantum chemical studies based on high-resolution protein structures and model compounds.

Authors:  Alok Jain; Venkatnarayan Ramanathan; Ramasubbu Sankararamakrishnan
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

10.  Structure-Function Analysis of Mammalian CYP2B Enzymes Using 7-Substituted Coumarin Derivatives as Probes: Utility of Crystal Structures and Molecular Modeling in Understanding Xenobiotic Metabolism.

Authors:  Manish B Shah; Jingbao Liu; Lu Huo; Qinghai Zhang; M Denise Dearing; P Ross Wilderman; Grazyna D Szklarz; C David Stout; James R Halpert
Journal:  Mol Pharmacol       Date:  2016-01-29       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.